Hepion Pharmaceuticals, Inc.
HEPA· OTC
HEPAHepion Pharmaceuticals, Inc.
Filed Apr 12, 2017 · 10-Q · 12 days after period end · 0001104659-17-023119
| Metric | Q1 2017 | Q1 2015 | Q1 2014 |
|---|---|---|---|
| Net Income | -$7.62M | -$1.47M | — |
| EPS Diluted | -$0.12 | -$0.07 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Hepion Pharmaceuticals, Inc. · CIK 1583771 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed Apr 12, 2017 · 12 d after period end
